Our group recently reported, in two late-stage metastatic breast cancer patients, on a novel phenotype of CTCs that, in addition to a strong CK signal, displayed a remarkable set of immune markers characteristic of CD4+ T-cells, including CD45, CD3, CD4, and the stemness marker CD44. The gene discussed is CD4; the disease is breast carcinoma.